Edition:
United States

Charles River Laboratories International Inc (CRL.N)

CRL.N on New York Stock Exchange

92.26USD
25 May 2017
Change (% chg)

-- (--)
Prev Close
$92.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
94,345
52-wk High
$92.87
52-wk Low
$67.21

CRL.N

Chart for CRL.N

About

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $4,395.21
Shares Outstanding(Mil.): 47.64
Dividend: --
Yield (%): --

Financials

  CRL.N Industry Sector
P/E (TTM): 27.10 141.29 17.43
EPS (TTM): 3.40 -- --
ROI: 8.16 2.17 -5.41
ROE: 19.82 0.10 -4.69

BRIEF-Charles River Laboratories reports updates to oncology business

May 16 Charles River Laboratories International Inc:

May 16 2017

BRIEF-Charles River Laboratories reports Q1 non-GAAP earnings per share $1.29

May 10 Charles River Laboratories International Inc:

May 10 2017

BRIEF-Nimbus Therapeutics enters strategic partnership with Charles River Laboratories

April 5 Charles River Laboratories International Inc:

Apr 05 2017

BRIEF-Charles River Laboratories reports Q4 GAAP earnings per share $0.93

Feb 14 Charles River Laboratories International Inc

Feb 14 2017

More From Around the Web

Earnings vs. Estimates